Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 804

1.

Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect.

Pederzoli F, Bandini M, Briganti A, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN, Vaishampayan UN, Théodore C, Rosenberg JE, Harshman LC, Bellmunt J, Galsky MD, Gallina A, Salonia A, Montorsi F, Necchi A; RISC Investigators.

Eur Urol. 2019 Jul 11. pii: S0302-2838(19)30522-6. doi: 10.1016/j.eururo.2019.06.032. [Epub ahead of print]

PMID:
31303258
2.

Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality.

Mistretta FA, Palumbo C, Knipper S, Mazzone E, Pecoraro A, Tian Z, Musi G, Perrotte P, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

World J Urol. 2019 Jul 11. doi: 10.1007/s00345-019-02869-6. [Epub ahead of print]

PMID:
31297629
3.

How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.

Palumbo C, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Antonelli A, Karakiewicz PI.

Urol Oncol. 2019 Jul 8. pii: S1078-1439(19)30220-0. doi: 10.1016/j.urolonc.2019.05.020. [Epub ahead of print]

PMID:
31296422
4.

Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates.

Mistretta FA, Mazzone E, Palumbo C, Knipper S, Tian Z, Nazzani S, Tilki D, Musi G, Perrotte P, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.

Urol Oncol. 2019 Jul 8. pii: S1078-1439(19)30224-8. doi: 10.1016/j.urolonc.2019.05.024. [Epub ahead of print]

PMID:
31296420
5.

Defining the Most Informative Intermediate Clinical Endpoints for Predicting Overall Survival in Patients Treated with Radical Prostatectomy for High-risk Prostate Cancer.

Martini A, Gandaglia G, Karnes RJ, Zaffuto E, Bianchi M, Gontero P, Chlosta P, Gratzke C, Graefen M, Tilki D, Cucchiara V, Mirone V, Kneitz B, Sanchez Salas R, Van Der Poel H, Tombal B, Spahn M, Joniau TS, Montorsi F, Briganti A; European Multicenter Prostate Cancer Clinical and Translational Research group (EMPaCT).

Eur Urol Oncol. 2019 Jul;2(4):456-463. doi: 10.1016/j.euo.2018.12.002. Epub 2018 Dec 24.

PMID:
31277783
6.

Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients.

Palumbo C, Knipper S, Dzyuba-Negrean C, Pecoraro A, Rosiello G, Tian Z, Shariat SF, Simeone C, Briganti A, Saad F, Berruti A, Antonelli A, Karakiewicz PI.

J Geriatr Oncol. 2019 Jun 27. pii: S1879-4068(19)30196-1. doi: 10.1016/j.jgo.2019.06.005. [Epub ahead of print]

PMID:
31257163
7.

68Ga-PSMA-11 PET Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective Study.

Farolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K, Fendler WP.

J Urol. 2019 Jun 24:101097JU0000000000000417. doi: 10.1097/JU.0000000000000417. [Epub ahead of print]

PMID:
31233369
8.

Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer.

Stabile A, Dell'Oglio P, Soligo M, De Cobelli F, Gandaglia G, Fossati N, Esposito A, Brembilla G, Karnes RJ, Montorsi F, Briganti A.

Eur Urol Oncol. 2019 Jun 13. pii: S2588-9311(19)30073-2. doi: 10.1016/j.euo.2019.05.006. [Epub ahead of print]

PMID:
31204312
9.

A Systematic Review of the Role of Definitive Local Treatment in Patients with Clinically Lymph Node-positive Prostate Cancer.

Ventimiglia E, Seisen T, Abdollah F, Briganti A, Fonteyne V, James N, Roach M 3rd, Thalmann GN, Touijer K, Chen RC, Cheng L.

Eur Urol Oncol. 2019 May;2(3):294-301. doi: 10.1016/j.euo.2019.02.001. Epub 2019 Mar 23. Review.

PMID:
31200844
10.

Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.

Bandini M, Briganti A, Plimack ER, Niegisch G, Yu EY, Bamias A, Agarwal N, Sridhar SS, Sternberg CN, Vaishampayan U, Théodore C, Rosenberg JE, Bellmunt J, Galsky MD, Montorsi F, Necchi A.

Eur Urol Oncol. 2019 May;2(3):248-256. doi: 10.1016/j.euo.2018.08.009. Epub 2018 Sep 7.

PMID:
31200838
11.

Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis.

Kimura S, Abufaraj M, Janisch F, Iwata T, Parizi MK, Foerster B, Fossati N, Briganti A, Egawa S, Hartenbach M, Shariat SF.

Prostate Cancer Prostatic Dis. 2019 May 30. doi: 10.1038/s41391-019-0156-z. [Epub ahead of print]

PMID:
31147628
12.

Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis.

Mazzone E, Mistretta FA, Knipper S, Palumbo C, Tian Z, Pecoraro A, Preisser F, Gallina A, Shariat SF, Saad F, Graefen M, Montorsi F, Briganti A, Karakiewicz PI.

BJU Int. 2019 May 30. doi: 10.1111/bju.14841. [Epub ahead of print]

PMID:
31144770
13.

18F-FDG PET/CT and Urothelial Carcinoma: Impact on Management and Prognosis-A Multicenter Retrospective Study.

Zattoni F, Incerti E, Dal Moro F, Moschini M, Castellucci P, Panareo S, Picchio M, Fallanca F, Briganti A, Gallina A, Fanti S, Schiavina R, Brunocilla E, Rambaldi I, Lowe V, Karnes JR, Evangelista L.

Cancers (Basel). 2019 May 20;11(5). pii: E700. doi: 10.3390/cancers11050700.

14.

Contemporary clinicopathological characteristics of pT0 prostate cancer at radical prostatectomy: A population-based study.

Knipper S, Tilki D, Mazzone E, Mistretta FA, Palumbo C, Pecoraro A, Tian Z, Briganti A, Saad F, Graefen M, Karakiewicz PI.

Urol Oncol. 2019 May 22. pii: S1078-1439(19)30187-5. doi: 10.1016/j.urolonc.2019.05.001. [Epub ahead of print]

PMID:
31129038
15.

Contemporary analysis of the effect of marital status on survival of prostate cancer patients across all stages: A population-based study.

Knipper S, Preisser F, Mazzone E, Mistretta FA, Palumbo C, Tian Z, Briganti A, Shariat SF, Saad F, Tilki D, Graefen M, Karakiewicz PI.

Urol Oncol. 2019 May 15. pii: S1078-1439(19)30156-5. doi: 10.1016/j.urolonc.2019.04.023. [Epub ahead of print]

PMID:
31103337
16.

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.

Bandini M, Preisser F, Nazzani S, Marchioni M, Tian Z, Mazzone E, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

Eur Urol Oncol. 2018 Aug;1(3):215-222. doi: 10.1016/j.euo.2018.03.007. Epub 2018 May 15.

PMID:
31102624
17.

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.

Nazzani S, Preisser F, Bandini M, Marchioni M, Tian Z, Soulières D, Montanari E, Ratti D, Acquati P, Briganti A, Shariat SF, Abdollah F, Carmignani L, Karakiewicz PI.

Eur Urol Oncol. 2018 Sep;1(4):346-351. doi: 10.1016/j.euo.2018.05.008. Epub 2018 May 31.

PMID:
31100257
18.

Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database.

Bandini M, Mazzone E, Preisser F, Nazzani S, Zaffuto E, Marchioni M, Tian Z, Pompe RS, Tilki D, Graefen M, Shariat SF, Montorsi F, Saad F, Briganti A, Karakiewicz P.

Eur Urol Oncol. 2018 Sep;1(4):314-320. doi: 10.1016/j.euo.2018.04.013. Epub 2018 May 15.

PMID:
31100253
19.

Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy.

Zaffuto E, Bandini M, Moschini M, Leyh-Bannurah SR, Gazdovich S, Dell'Oglio P, Gallina A, Shariat SF, Briganti A, Montorsi F, Saad F, Karakiewicz PI.

Eur Urol Oncol. 2018 Jun;1(2):169-175. doi: 10.1016/j.euo.2018.02.001. Epub 2018 May 15.

PMID:
31100242
20.

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer.

Preisser F, Marchioni M, Nazzani S, Bandini M, Tian Z, Saad F, Pompe RS, Briganti A, Budäus L, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Eur Urol Oncol. 2018 Jun;1(2):160-168. doi: 10.1016/j.euo.2018.03.006. Epub 2018 May 15.

PMID:
31100241
21.

Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.

Stabile A, Dell'Oglio P, Gandaglia G, Fossati N, Brembilla G, Cristel G, Dehò F, Scattoni V, Maga T, Losa A, Gaboardi F, Cardone G, Esposito A, De Cobelli F, Del Maschio A, Montorsi F, Briganti A.

Eur Urol Oncol. 2018 Jun;1(2):120-128. doi: 10.1016/j.euo.2018.02.002. Epub 2018 May 15.

PMID:
31100235
22.

Is Robot-assisted Surgery Contraindicated in the Case of Partial Nephrectomy for Complex Tumours or Relevant Comorbidities? A Comparative Analysis of Morbidity, Renal Function, and Oncologic Outcomes.

Larcher A, Capitanio U, De Naeyer G, Fossati N, D'Hondt F, Muttin F, De Groote R, Guazzoni G, Salonia A, Briganti A, Montorsi F, Mottrie A.

Eur Urol Oncol. 2018 May;1(1):61-68. doi: 10.1016/j.euo.2018.01.001. Epub 2018 May 15.

PMID:
31100229
23.

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases.

Heidenreich A, Fossati N, Pfister D, Suardi N, Montorsi F, Shariat S, Grubmüller B, Gandaglia G, Briganti A, Karnes RJ.

Eur Urol Oncol. 2018 May;1(1):46-53. doi: 10.1016/j.euo.2018.03.002. Epub 2018 May 15.

PMID:
31100228
24.

Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.

Stabile A, Dell'Oglio P, De Cobelli F, Esposito A, Gandaglia G, Fossati N, Brembilla G, Cristel G, Cardone G, Deho' F, Losa A, Suardi N, Gaboardi F, Del Maschio A, Montorsi F, Briganti A.

Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.

PMID:
31100225
25.

Welcome to European Urology Oncology: Your New Journal, Where Multiple Disciplines Meet To Improve Care of Patients with Genitourinary Cancers.

Briganti A, Albiges L, Giannarini G, Kamat AM, Nguyen PL.

Eur Urol Oncol. 2018 May;1(1):1-2. doi: 10.1016/j.euo.2018.04.002. Epub 2018 May 15. No abstract available.

PMID:
31100222
26.

Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.

Gandaglia G, Albers P, Abrahamsson PA, Briganti A, Catto JWF, Chapple CR, Montorsi F, Mottet N, Roobol MJ, Sønksen J, Wirth M, van Poppel H.

Eur Urol. 2019 Aug;76(2):142-150. doi: 10.1016/j.eururo.2019.04.033. Epub 2019 May 12.

PMID:
31092338
27.

Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis.

Kimura S, Iwata T, Foerster B, Fossati N, Briganti A, Nasu Y, Egawa S, Abufaraj M, Shariat SF.

Int J Urol. 2019 May 13. doi: 10.1111/iju.14005. [Epub ahead of print] Review.

PMID:
31083783
28.

Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study.

Knipper S, Preisser F, Mazzone E, Mistretta FA, Tian Z, Briganti A, Zorn KC, Saad F, Tilki D, Graefen M, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jun;17(3):231-237.e2. doi: 10.1016/j.clgc.2019.04.009. Epub 2019 Apr 16.

PMID:
31080021
29.

Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration.

Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, D Andrea D, Tan WS, Kelly JD, Simone G, Gallucci M, Meraney A, Krishna S, Konety BR, Antonelli A, Simeone C, Baumeister P, Mattei A, Briganti A, Gallina A, Montorsi F, Rink M, Aziz A, Karakiewicz PI, Rouprêt M, Koupparis A, Scherr DS, Ploussard G, Sooriakumaran P, Shariat SF, Moschini M; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group.

BJU Int. 2019 May 4. doi: 10.1111/bju.14791. [Epub ahead of print]

PMID:
31055865
30.

Requiem for Open Radical Cystectomy in Bladder Cancer Patients.

Gandaglia G, Larcher A, Gallina A, Fossati N, Briganti A, Montorsi F.

Eur Urol Oncol. 2019 Mar;2(2):196-197. doi: 10.1016/j.euo.2018.07.004. Epub 2018 Aug 6.

PMID:
31017096
31.

The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis.

Mazzone E, Preisser F, Nazzani S, Tian Z, Zaffuto E, Gallina A, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

J Geriatr Oncol. 2019 Jul;10(4):623-631. doi: 10.1016/j.jgo.2019.04.011. Epub 2019 Apr 19.

PMID:
31010691
32.

Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma.

Nazzani S, Preisser F, Mazzone E, Marchioni M, Bandini M, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.

Clin Genitourin Cancer. 2019 Jun;17(3):e602-e611. doi: 10.1016/j.clgc.2019.03.003. Epub 2019 Mar 29.

PMID:
31005472
33.

Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.

Palumbo C, Cyr SJ, Mazzone E, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Kapoor A, Antonelli A, Karakiewicz PI.

J Endourol. 2019 Jul;33(7):606-613. doi: 10.1089/end.2019.0179. Epub 2019 May 17.

PMID:
30990074
34.

Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis.

Iwata T, Kimura S, Foerster B, Fossati N, Briganti A, Karakiewicz PI, Gust KM, Egawa S, Nasu Y, Abufaraj M, Shariat SF.

World J Urol. 2019 Apr 11. doi: 10.1007/s00345-019-02708-8. [Epub ahead of print] Review.

PMID:
30976902
35.

Proximal RUMM block in dogs: preliminary results of cadaveric and clinical studies.

Tayari H, Otero P, Rossetti A, Breghi G, Briganti A.

Vet Anaesth Analg. 2019 May;46(3):384-394. doi: 10.1016/j.vaa.2018.11.009. Epub 2019 Jan 25.

PMID:
30962041
36.

Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United States.

Mazzone E, Mistretta FA, Knipper S, Tian Z, Larcher A, Widmer H, Zorn K, Capitanio U, Graefen M, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.

J Endourol. 2019 Jun;33(6):438-447. doi: 10.1089/end.2018.0840.

PMID:
30931607
37.

Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy.

Dell'Oglio P, Tian Z, Leyh-Bannurah SR, Larcher A, Mazzone E, Moschini M, Trudeau V, Stabile A, Gallina A, Suardi N, Capitanio U, Mottrie A, Briganti A, Montorsi F, Rochefort CM, Karakiewicz PI.

Ann Surg Oncol. 2019 Jun;26(6):1942-1949. doi: 10.1245/s10434-019-07313-y. Epub 2019 Mar 27.

PMID:
30919224
38.

The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.

Zamboni S, Moschini M, Gallina A, Colombo R, Montorsi F, Briganti A, Salonia A, Antonelli A, Simeone C, Belotti S, Cristinelli L, Mattei A, Baumeister P.

World J Urol. 2019 Mar 25. doi: 10.1007/s00345-019-02734-6. [Epub ahead of print]

PMID:
30911811
39.

Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy.

Zamboni S, Foerster B, Abufaraj M, Seisen T, Roupret M, Colin P, De la Taille A, Di Bona C, Peyronnet B, Bensalah K, Herout R, Wirth MP, Novotny V, Soria F, Chlosta P, Antonelli A, Simeone C, Baumeister P, Mattei A, Montorsi F, Simone G, Gallucci M, Matsumoto K, Karakiewicz PI, Briganti A, Xylinas E, Shariat SF, Moschini M; Upper Tract Urothelial Carcinoma Collaboration Group; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group.

BJU Int. 2019 Mar 25. doi: 10.1111/bju.14751. [Epub ahead of print]

PMID:
30908835
40.

Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?

Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Gandaglia G, Briganti A, de Visschere P, Mathieu R, Valerio M, van den Bergh R, Ost P, Mirvald C, Tilki D, Ploussard G, Surcel C; EAU-YAU Prostate Cancer Working Party.

Cancer Treat Rev. 2019 May;75:20-26. doi: 10.1016/j.ctrv.2019.03.001. Epub 2019 Mar 11. Review.

PMID:
30875581
41.

Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis.

Nazzani S, Bandini M, Preisser F, Mazzone E, Marchioni M, Tian Z, Stubinski R, Clementi MC, Saad F, Shariat SF, Montanari E, Briganti A, Carmignani L, Karakiewicz PI.

Surg Oncol. 2019 Mar;28:201-207. doi: 10.1016/j.suronc.2019.01.011. Epub 2019 Jan 29.

PMID:
30851901
42.

Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery.

Moschini M, Martini A, Zamboni S, Mattei A, Baumeister P, Di Bona C, Dell'Oglio P, Zaffuto E, Burgio G, Shariat SF, Sanchez-Salas R, Cathelineau X, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.

Clin Genitourin Cancer. 2019 Jun;17(3):e541-e548. doi: 10.1016/j.clgc.2019.02.001. Epub 2019 Feb 13.

PMID:
30850337
43.

Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study.

Fossati N, Robesti D, Karnes RJ, Soligo M, Boorjian SA, Bossi A, Coraggio G, Di Muzio N, Cozzarini C, Noris Chiorda B, Gandaglia G, Scarcella S, Bartkowiak D, Böhmer D, Shariat S, Goldner G, Battaglia A, Joniau S, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Wiegel T, Briganti A.

Eur Urol. 2019 Feb 21. pii: S0302-2838(19)30112-5. doi: 10.1016/j.eururo.2019.02.004. [Epub ahead of print]

PMID:
30799187
44.

Robot-assisted versus open cystectomy in the RAZOR trial.

Larcher A, Gandaglia G, Wiklund P, Mottrie A, Briganti A, Montorsi F; European Association of Urology Robotic Urology Section.

Lancet. 2019 Feb 16;393(10172):645. doi: 10.1016/S0140-6736(18)33006-X. Epub 2019 Feb 14. No abstract available.

PMID:
30782339
45.

Integrating radon and thoron flux data with gamma radiation mapping in radon-prone areas. The case of volcanic outcrops in a highly-urbanized city (Roma, Italy).

Lucchetti C, Briganti A, Castelluccio M, Galli G, Santilli S, Soligo M, Tuccimei P.

J Environ Radioact. 2019 Jun;202:41-50. doi: 10.1016/j.jenvrad.2019.02.004. Epub 2019 Feb 16.

PMID:
30776702
46.

Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.

Mistretta FA, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat SF, de Cobelli O, Karakiewicz PI.

Cancer Epidemiol. 2019 Apr;59:135-142. doi: 10.1016/j.canep.2019.02.002. Epub 2019 Feb 13.

PMID:
30771698
47.

Comparison of perioperative outcomes between open and minimally invasive nephroureterectomy: A population-based analysis.

Nazzani S, Bazinet A, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Saad F, Zorn KC, Montanari E, Briganti A, Carmignani L, Karakiewicz PI.

Int J Urol. 2019 Apr;26(4):487-492. doi: 10.1111/iju.13916. Epub 2019 Feb 12.

PMID:
30756440
48.

Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.

Mazzone E, Nazzani S, Knipper S, Tian Z, Preisser F, Gallina A, Soulières D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.

Eur J Surg Oncol. 2019 Jul;45(7):1253-1259. doi: 10.1016/j.ejso.2019.01.218. Epub 2019 Feb 3.

PMID:
30755341
49.

Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.

Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, Dickinson L, Allen C, Punwani S, Jameson C, Freeman A, McCartan N, Montorsi F, Briganti A, Ahmed HU, Emberton M, Moore CM.

BJU Int. 2019 Feb 12. doi: 10.1111/bju.14710. [Epub ahead of print]

PMID:
30753756
50.

The Impact of Experience on the Risk of Surgical Margins and Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Learning Curve Study.

Bravi CA, Tin A, Vertosick E, Mazzone E, Martini A, Dell'Oglio P, Stabile A, Gandaglia G, Fossati N, Suardi N, Gallina A, Briganti A, Montorsi F, Vickers A.

J Urol. 2019 Jul;202(1):108-113. doi: 10.1097/JU.0000000000000147. Epub 2019 Jun 7.

PMID:
30747873

Supplemental Content

Loading ...
Support Center